LabCorp to Announce Second Quarter Financial Results on July 25, 2019

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 25, 2019-- LabCorp® (NYSE: LH) will release its second quarter of 2019 financial results before the market opens on Thursday, July 25, 2019 , followed by a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

LabCorp and Mount Sinai Health System Collaborate to Establish Digital and AI-Enabled Pathology Center of Excellence

Philips IntelliSite Pathology Solution will be deployed across the Mount Sinai Health System to support greater efficiency and help improve patient care BURLINGTON, N.C. & NEW YORK & AMSTERDAM--(BUSINESS WIRE)--Jun. 18, 2019-- LabCorp® (NYSE: LH) and the Mount Sinai Health System today announced

LabCorp and QIAGEN Announce New therascreen PIK3CA Mutation Analysis Companion Diagnostic for Metastatic Breast Cancer

LabCorp Announces New Leadership Roles

David P. King , current chairman, president and CEO of LabCorp, to become executive chairman of the board of directors effective Nov. 1 , retiring Oct. 31 as president and CEO Adam H. Schechter , current lead independent director of LabCorp and longtime Merck executive, to become president and CEO

LabCorp Announces New Term Loan Facility

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 3, 2019-- On June 3, 2019 , LabCorp® (NYSE: LH) entered into a new Term Loan Credit Agreement, which provides for a two-year term loan credit facility in the principal amount of $850 million (the “New Term Loan Facility”). Bank of America, N.A.